Double maintains 4 strategies that include BRKR - Bruker Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGRO | -0.15% | $921.94M | +1.43% | 3.75% |
CNK | 0.18% | $3.70B | +79.80% | 0.50% |
VHC | 0.18% | $37.77M | +135.71% | 0.00% |
RLMD | 0.19% | $25.44M | -74.70% | 0.00% |
CARV | 0.19% | $8.38M | -11.35% | 0.00% |
DAO | -0.20% | $275.27M | +136.56% | 0.00% |
LITB | 0.29% | $21.77M | -74.81% | 0.00% |
YORW | -0.31% | $470.03M | -9.58% | 2.66% |
BTI | 0.34% | $106.86B | +59.05% | 6.30% |
BTCT | -0.40% | $21.81M | +56.22% | 0.00% |
TIGO | -0.40% | $6.31B | +49.29% | 4.76% |
AMSF | -0.42% | $860.50M | +12.07% | 3.32% |
UTZ | -0.53% | $1.16B | -26.39% | 1.79% |
DG | 0.72% | $24.53B | -10.79% | 2.13% |
UGP | 0.74% | $3.34B | -23.96% | 3.96% |
LTM | 0.91% | $12.15B | -96.20% | 2.54% |
STG | 0.97% | $32.24M | -0.16% | 0.00% |
UUU | -1.11% | $7.36M | +96.30% | 0.00% |
TH | 1.15% | $692.57M | -8.53% | 0.00% |
TU | -1.26% | $24.52B | -0.06% | 7.11% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LGOV | -0.08% | $689.06M | 0.67% |
CTA | -0.08% | $1.09B | 0.76% |
CGCB | 0.18% | $2.32B | 0.27% |
FIXD | 0.21% | $3.37B | 0.65% |
CGSD | 0.32% | $1.27B | 0.25% |
VNLA | 0.36% | $2.57B | 0.23% |
SHM | 0.42% | $3.39B | 0.2% |
SPIP | 0.49% | $953.45M | 0.12% |
IBD | -0.56% | $381.73M | 0.43% |
SPSK | 0.61% | $314.48M | 0.5% |
IBMO | -0.62% | $519.63M | 0.18% |
IAGG | 0.63% | $10.25B | 0.07% |
TIP | -0.63% | $13.74B | 0.18% |
BNDW | -0.73% | $1.24B | 0.05% |
HYD | -0.74% | $3.28B | 0.32% |
JPIB | 0.75% | $808.33M | 0.5% |
BAB | 0.75% | $918.78M | 0.28% |
IBND | -0.78% | $332.16M | 0.5% |
ISTB | -0.80% | $4.41B | 0.06% |
JBND | -0.86% | $2.13B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -39.48% | $153.01M | 0.85% |
TAIL | -38.72% | $107.77M | 0.59% |
BTAL | -37.88% | $298.87M | 1.43% |
IVOL | -36.63% | $358.39M | 1.02% |
STPZ | -25.26% | $451.45M | 0.2% |
SHYM | -24.33% | $324.05M | 0.35% |
XONE | -22.00% | $634.70M | 0.03% |
FTSD | -21.59% | $228.13M | 0.25% |
VTIP | -20.70% | $15.09B | 0.03% |
SPTS | -20.64% | $5.78B | 0.03% |
FXY | -18.67% | $857.17M | 0.4% |
UTWO | -18.42% | $374.41M | 0.15% |
SCHO | -17.33% | $10.93B | 0.03% |
TPMN | -16.80% | $30.67M | 0.65% |
VGSH | -16.03% | $22.40B | 0.03% |
IBTH | -15.82% | $1.57B | 0.07% |
STIP | -15.80% | $12.58B | 0.03% |
TDTT | -15.48% | $2.58B | 0.18% |
ULST | -13.29% | $663.99M | 0.2% |
SMB | -13.04% | $272.68M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -15.72% | $5.10K | -99.92% | 0.00% |
CME | -13.07% | $97.17B | +37.77% | 3.95% |
CBOE | -11.65% | $23.34B | +31.58% | 1.12% |
MO | -10.54% | $100.92B | +30.61% | 6.82% |
AWK | -8.81% | $27.42B | +9.74% | 2.22% |
ED | -8.05% | $36.95B | +12.52% | 3.26% |
VSTA | -7.58% | $331.23M | +31.32% | 0.00% |
MKTX | -7.09% | $8.44B | +11.89% | 1.32% |
KR | -6.31% | $43.03B | +28.80% | 1.97% |
PPC | -5.94% | $10.70B | +45.42% | 0.00% |
TEF | -5.70% | $29.51B | +15.71% | 5.96% |
DUK | -5.58% | $90.43B | +14.83% | 3.58% |
SBS | -5.22% | $14.24B | +53.69% | 3.17% |
EXC | -4.86% | $43.29B | +23.40% | 3.60% |
TMUS | -4.05% | $262.22B | +32.88% | 1.44% |
PRA | -3.97% | $1.18B | +78.48% | 0.00% |
T | -3.57% | $203.92B | +60.93% | 3.93% |
MSIF | -3.18% | $831.23M | +47.01% | 6.11% |
MCK | -2.91% | $89.80B | +22.74% | 0.39% |
FDP | -2.04% | $1.56B | +45.08% | 3.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
A | 78.17% | $34.01B | -10.09% | 0.81% |
TECH | 76.88% | $8.08B | -33.45% | 0.62% |
MTD | 74.85% | $24.79B | -18.26% | 0.00% |
RVTY | 73.88% | $11.32B | -14.64% | 0.29% |
TMO | 69.17% | $156.72B | -27.89% | 0.39% |
WAT | 67.65% | $20.59B | +14.98% | 0.00% |
IQV | 67.51% | $27.48B | -26.96% | 0.00% |
BIO | 63.94% | $6.26B | -18.74% | 0.00% |
DHR | 62.97% | $146.51B | -22.63% | 0.55% |
AZTA | 62.18% | $1.41B | -45.19% | 0.00% |
ILMN | 62.01% | $13.86B | -17.20% | 0.00% |
QGEN | 61.30% | $10.12B | +2.70% | 0.00% |
RGEN | 59.60% | $7.42B | -7.61% | 0.00% |
LFUS | 58.58% | $5.55B | -13.78% | 1.23% |
TXG | 58.22% | $1.35B | -49.51% | 0.00% |
ENTG | 57.32% | $11.88B | -43.03% | 0.51% |
POWI | 57.26% | $3.25B | -23.96% | 1.44% |
SWK | 55.93% | $10.54B | -21.67% | 4.87% |
CRL | 55.46% | $7.42B | -29.34% | 0.00% |
DD | 55.09% | $29.04B | -13.82% | 2.30% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FBT | 68.62% | $1.05B | 0.54% |
RSPH | 68.33% | $744.13M | 0.4% |
BBH | 66.06% | $334.99M | 0.35% |
IBB | 65.82% | $5.23B | 0.45% |
MOAT | 65.72% | $12.77B | 0.47% |
FXH | 65.66% | $915.23M | 0.62% |
PBE | 63.54% | $229.19M | 0.58% |
FHLC | 62.14% | $2.45B | 0.084% |
QQQJ | 61.52% | $614.21M | 0.15% |
VHT | 61.52% | $15.31B | 0.09% |
SMOT | 61.19% | $381.72M | 0.49% |
IYH | 60.84% | $2.77B | 0.39% |
DSTL | 60.14% | $1.83B | 0.39% |
GNOM | 59.76% | $44.34M | 0.5% |
FLQM | 58.66% | $1.64B | 0.3% |
XHE | 58.54% | $178.99M | 0.35% |
XLV | 58.41% | $34.47B | 0.09% |
QVAL | 58.34% | $373.55M | 0.29% |
JVAL | 58.15% | $528.96M | 0.12% |
SNSR | 57.48% | $225.73M | 0.68% |
Yahoo
Scientific instrument company Bruker (NASDAQ:BRKR). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $801.4 million. The company’s full-year revenue guidance of $3.52 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.47 per share was 5.9% above analysts’ consensus estimates.
Yahoo
As the United States market continues to navigate the complexities of US-China trade talks, major indices like the S&P 500 and Nasdaq Composite have reached their highest levels since February. In this environment, identifying stocks that may be trading below their estimated value can present opportunities for investors looking to capitalize on potential market inefficiencies.
Yahoo
BRKR strengthens its MS-based metabolomics platform with the biocrates deal, boosting investor sentiment.
Yahoo
As the U.S. stock market continues its upward trajectory, buoyed by positive economic indicators and easing trade tensions between the U.S. and China, investors are increasingly focused on growth stocks that demonstrate strong insider ownership. In this context, companies like Bruker stand out as they align with current market optimism by potentially offering stability and confidence through significant insider investment.
Finnhub
Presenter SpeechTycho Peterson We're going to kick it off. I'm Tycho Peterson. It's my pleasure to introduce Bruker.QuestionTycho Peterson Frank, maybe just to kick it off, came out of ASMS earlier...
Yahoo
BILLERICA, Mass., June 03, 2025--Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker’s continued investment in applied markets, particularly in therapeutic drug monitoring (TDM), drugs of abuse (DoA) analysis and environmental analysis.
Current Value
$39.511 Year Return
Current Value
$39.511 Year Return